Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 13 trials

Late-Stage Pipeline

31%

4 trials in Phase 3/4

Results Transparency

0 of 0 completed trials have results

Key Signals

7 recruiting

Enrollment Performance

Analytics

N/A

5(45.5%)

Phase 2

2(18.2%)

Phase 3

2(18.2%)

Phase 4

2(18.2%)

11Total

N/A(5)

Phase 2(2)

Phase 3(2)

Phase 4(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (13)

Showing 13 of 13 trials

NCT07296575Active Not Recruiting

Ultrasound Large-scale Model in Thyroid Field: A Multi-center Study on Medical-Engineering Integration

Role: collaborator

NCT07155265Phase 3Not Yet Recruiting

REMIMID-ICU: Remimazolam vs Midazolam for Deep Sedation in Hemodynamically Unstable, Mechanically Ventilated Adults

Role: lead

NCT06841822Not ApplicableRecruiting

The Impact of Ultrasound-Guided Superficial and Deep Paravertebral Nerve Blocks at the Superior Costotransverse Ligament on Hemodynamics During the Induction Phase of Thoracoscopic Lung Lobectomy: A Multicenter, Double-Blind, Randomized Controlled Trial

Role: collaborator

NCT04974138Phase 4Recruiting

China Stroke Primary Prevention Trial 2 for Participants With H-type Hypertension and MTHFR 677 CC/CT Genotype (CSPPT2-CC/CT)

Role: collaborator

NCT04974151Phase 4Recruiting

China Stroke Primary Prevention Trial 2 for Participants With Hypertension and MTHFR 677 TT Genotype

Role: collaborator

NCT05522582Phase 2Active Not Recruiting

Methotrexate Combined With Immunotherapy During Radiotherapy for Solid Tumors

Role: lead

NCT06515964Recruiting

China Early Esophageal Cancer Cohort

Role: collaborator

NCT06429865Not ApplicableEnrolling By Invitation

Cytosponge in Surveillance After Endoscopic Submucosal Dissection for Esophageal Squamous Cell Carcinoma

Role: collaborator

NCT06254690Phase 2Recruiting

The Dosing Regimen of Pyrotinib in HER2-positive Advanced First-line Breast Cancer: a Phase II Clinical Study

Role: collaborator

NCT06232694Not ApplicableRecruiting

Clinical Study Protocol of IAV-induced Remission Followed by Consolidation Therapy With MDCyta+Ven in ND-AML

Role: collaborator

NCT05909293Not ApplicableRecruiting

Clinical Study Protocol of Maintenance Therapy With Venetoclax in Elderly Patients With AML in First Complete Remission

Role: collaborator

NCT05264883Phase 3Unknown

Venetoclax+HMA+Aclarubicin Versus Venetoclax+HMA in Treatment-Naive Elderly Patients With AML

Role: collaborator

NCT05343377Not ApplicableNot Yet Recruiting

A Clinical Study of the Value of Circulating Free Methylated EBV DNA in Extranodal NK/T Cell Lymphoma

Role: collaborator

All 13 trials loaded